Inhibition of the catalytic activity of human transaldolase by antibodies and site-directed mutagenesis

FEBS Lett. 1996 Jan 8;378(2):161-5. doi: 10.1016/0014-5793(95)01446-2.

Abstract

Transaldolase is a key enzyme of the pentose phosphate pathway. While antibody (Ab) 169, directed against the N-terminal 139 residues of human transaldolase (TAL-H), had no effect on enzyme activity, Ab 12484 raised against full length and functional recombinant TAL-H inhibited catalytic activity. This tentatively mapped the catalytic site to the C-terminal 140-336 amino acid portion of TAL-H. Dihydroxyacetone transfer reactions catalyzed by transaldolase depend on Schiff base formation by a lysine residue. Replacement of lysine-142 by glutamine using site-directed mutagenesis resulted in a complete loss of enzyme activity, suggesting that lysine-142 is essential for the catalytic activity of TAL-H.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Antibodies / pharmacology*
  • Base Sequence
  • Binding Sites
  • Catalysis
  • Humans
  • Lysine
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed*
  • Peptide Fragments / antagonists & inhibitors
  • Recombinant Proteins / metabolism
  • Structure-Activity Relationship
  • Transaldolase / antagonists & inhibitors*
  • Transaldolase / chemistry
  • Transaldolase / genetics

Substances

  • Antibodies
  • Peptide Fragments
  • Recombinant Proteins
  • Transaldolase
  • Lysine